| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 251.62B | 251.76B | 248.70B | 236.63B | 242.06B | 214.51B |
| Gross Profit | 68.91B | 68.37B | 67.91B | 64.14B | 56.80B | 54.09B |
| EBITDA | 27.27B | 37.08B | 35.62B | 33.08B | 25.98B | 28.29B |
| Net Income | 17.23B | 18.53B | 16.90B | 15.13B | 10.06B | 13.12B |
Balance Sheet | ||||||
| Total Assets | 278.39B | 326.44B | 288.06B | 274.74B | 252.69B | 242.15B |
| Cash, Cash Equivalents and Short-Term Investments | 57.25B | 60.21B | 65.67B | 62.02B | 50.99B | 47.18B |
| Total Debt | 26.72B | 47.58B | 30.63B | 30.49B | 30.30B | 17.22B |
| Total Liabilities | 94.67B | 119.13B | 98.33B | 98.19B | 94.62B | 79.42B |
| Stockholders Equity | 167.89B | 190.50B | 173.39B | 161.81B | 145.23B | 145.25B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.09B | 18.49B | 20.01B | 12.21B | 4.99B |
| Operating Cash Flow | 0.00 | 8.78B | 26.75B | 28.48B | 19.85B | 11.69B |
| Investing Cash Flow | 0.00 | -27.47B | -11.12B | -7.57B | -9.06B | -8.34B |
| Financing Cash Flow | 0.00 | 10.77B | -16.79B | -11.17B | -9.36B | -1.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥617.79B | 17.43 | 13.63% | 1.95% | -1.79% | 1.03% | |
73 Outperform | ¥177.28B | 10.76 | ― | 2.66% | -4.58% | 51.25% | |
71 Outperform | ¥224.76B | 18.16 | ― | 3.90% | 1.23% | 11.14% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥915.68B | 9.71 | 7.53% | 3.13% | 0.89% | -6.71% | |
58 Neutral | ¥360.50B | 4.33 | 8.35% | 2.73% | -3.16% | -32.06% | |
46 Neutral | ¥307.83B | -3.58 | -20.43% | 3.72% | -13.16% | -410.43% |